Clinical Trial Update: Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of SIF001 in healthy volunteers and epilepsy patients; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• SIF001

Snippet

Sponsor: Suninflam Inc | Conditions: Epilepsy, Healthy Volunteer | Phase 1 | Status: RECRUITING